9 Meters Biopharma (NASDAQ:NMTR) Price Target Increased to $5.00 by Analysts at Oppenheimer

Retrieved on: 2022-09-28 07:35:54

Tags for this article:

Click the tags to see associated articles and topics

9 Meters Biopharma (NASDAQ:NMTR) Price Target Increased to $5.00 by Analysts at Oppenheimer. View article details on hiswai:

Excerpt

Maxim Group lowered 9 Meters Biopharma from a buy rating to a hold rating in a report on Friday, July 1st. Truist Financial reduced their price ...

Article found on: reporter.am